2m 2m 2m 2m 2m 2m 2m
Syndax Pharmaceu (SNDX)
NASDAQ
$13.57+$0.42 (+3.19%)
Price as of Oct 22, 2026 7:30 PM EDT- $1.2BMarket Cap
- -12.97%1-Year Change
- BiotechnologyIndustry
Syndax Pharmaceu (SNDX)
$13.57+$0.42 (+3.19%)
SNDX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $13.15 | ||
Change | -$0.10 (-0.75%) | ||
Open | $13.32 | ||
High | $13.59 | ||
Low | $13.10 | ||
Previous Close | $13.25 | ||
Volume | 2,587,704 | ||
30-Day Average Volume | 2,262,250 | ||
1-Week Change | -2.81% | ||
1-Month Change | -27.23% | ||
1-Year Change | -12.97% | ||
3-Year Change | 14.25% | ||
5-Year Change | -29.45% | ||
Fundamentals | |||
Shares Outstanding | 89.3M | ||
Total Assets | $703.7M | ||
Market Cap | $1.2B | ||
Enterprise Value | $2.0B | ||
Period: QTR TTM FY | |||
Revenue | $54.7M | ||
Net Income | -$49.4M | ||
Free Cash Flow | -$30.3M | ||
EBIT | -$37.3M | ||
EBITDA | -$32.3M | ||
Net Working Capital | $575.4M | ||
EPS | -$0.55 | ||
Enterprise Value/EBITDA | -63 | ||
Enterprise Value/Revenue | 37 | ||
P/B | 78 | ||
P/E | -24 | ||
PEG | 2 | ||
Price/Free Cash Flow | -39 | ||
Price/Operating Cash Flow | -39 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue